April 19, 2018 8:18am

Eeny, meeny, miny, moe as investors are left to speculation with traders barking, algorithms ruling and ETFs pooling; it might be a good day to hide

It’s a good day for a safety check or was it sanity verification!

 

While Capricor (CAPR) keeps the mouse models pre-clinical alive

 

Pre-open indication:  I am abstaining

 

Where the understanding of the indications sheds light on share pricing!

Lower open expected

Dow futures are DOWN -0.10% (-25 points) and NASDAQ futures are DOWN -0.19% (-13 points)

 

U.S. stock index futures fluctuated ahead of Thursday's open

EU markets were mixed, as investors reacted to fresh earnings and soaring oil prices.

Asian markets recorded gains, as oil prices extended gains

 

Data docket: Jobless claims and the Philadelphia Fed manufacturing business outlook survey are both due out at 8:30 a.m. ET.

Political front: Investors will be watching out for political news, with rising tensions in the Middle East after the U.S., U.K. and France conducted missile strikes against the Syrian government last weekend, in response to a suspected chemical attack.

 

Today’s indications:

  • The iShares Nasdaq Biotechnology (IBB) is NOT indicating in Thursday’s pre-market;
  • The SPDR S&P Biotech ETF (XBI) is NOT indicating in Thursday’s pre-market;
  • The Health Care Select Sector SPDR ETF (XLV) is NOT indicating in Thursday’s pre-open;
  • The iShares Russell 2000 (IWM) is indicating a NEGATIVE -0.11% downside in Thursday’s pre-open

 

Henry’omics:

Today’s moves: risk in our sector is ALWAYS there however, the ‘Trump risk’ in the markets is still hard to quantify – who knows what will “infect” this market, Yet the old mantra spikes, “sticks and stones will break my bones but, names will never hurt me!

 

From Wednesday night’s newsletter: “a tempestuous April and hard for individual investors to be noticed. The stain of speculation and trading risk are weighted to harm investors. Share pricing needs to be stronger as sector guidance is not evident.”

I also stated, “It’s funny how many are NOT buying the dip … My view of the session: Investors are “smelling” depreciation as Q1 (LPS or loss-per-share) numbers are about to become evident which begets MY usual admonishment – WHAT’s SUSTAINABLE?”

 

A re-cap:

  • Wednesday’s decliners ranged from -0.06% <CLLS -$0.02> to -10.96% <NWBO -$0.025 > in 24 equities;
  • Wednesday’s gainers ranged from +0.38% <BSTG +$0.01 > to +14.01% <KOOL +$0.22 > in 14 equities;

 

Consider the iShares NASDAQ Biotechnology (IBB) over the last twelve (13) sessions was up +3.02% which closed up +0.07% on Wednesday.

My evaluation:  we are headed for a day of muted action?

 

Company in my headlights:

 

…In accord to the title, which are the "chosen" ups or the  "counted downs". Some sessions, you just have to wait before drinking the “hemlock” or not … as better bourbon will come available!

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.